BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Epitome Biosystems Receives $500,000 SBIR Grant From National Science Foundation


10/19/2005 5:13:21 PM

WALTHAM, Mass., Oct. 17 /PRNewswire/ -- Epitome Biosystems announced today the receipt of a Phase II SBIR grant from the National Science Foundation. The Company will use the grant of $500,000 over two years to develop an antibody array that will integrate the measurement of phosphoproteins from three important cell signaling pathways into a single assay system. Upon successful completion of the development program, Epitome intends to market the resulting product to the research community, either directly or through a distribution partner.

Epitome's EpiTag(TM) technology enables the identification of unique amino acid sequences or "tags" within a protein. Antibodies raised against these peptides tags, rather than the entire protein, have predetermined specificity and high affinity and can precisely target specific regions of phosphorylation within the protein. The EpiTag assay harnesses the power of these antibodies by measuring peptide fragments, released from the protein by digestion, rather than the entire protein. By reducing the measurement system to a peptide level, Epitome provides a universal, efficient and scalable method for developing and conducting multiplex protein assays.

Neal Gordon, Ph.D., President of Epitome stated, "the SBIR Phase II award not only provides a source of development funding but also represents an important endorsement of our technology platform. We expect to deliver a compelling new measurement tool for scientists studying cell signaling pathways that play critical roles in cancer and other diseases."

In May 2004, Epitome Biosystems was awarded Phase I of the SBIR grant to demonstrate feasibility of the EpiTag technology platform for phosphoprotein analysis. During the Phase I project, the company developed highly specific and high affinity antibodies for peptide tags identified for proteins in the MapK signaling pathway and used the antibodies in an array format for multiplex measurement of protein phosphorylation. The recent award will enable Epitome Biosystems to develop commercial products with expanded array content that encompass three cell signaling pathways.

About Epitome Biosystems

Epitome Biosystems is a pioneer in the development of a new breed of protein measurement tools. Its proprietary EpiTag(TM) technology delivers highly specific antibodies and assay standards for quantitation of any protein based solely on sequence. These reagents easily interface with any measurement system including bead based and planar array platforms and are particularly useful in developing micro-scale immunoassays. Epitome Biosystems is backed by funding from Flagship Ventures and Vinod Khosla, with offices in Waltham, MA. For more information, visit www.epitomebiosystems.com.

Epitome Biosystems

CONTACT: Neal F. Gordon, Ph.D. of Epitome Biosystems, +1-781-209-2370,ngordon@epitomebiosystems.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES